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Abstract
The emergence of total drug-resistant tuberculosis (TDR-TB) has made the discovery of new
therapies for tuberculosis urgent. The cytoplasmic enzymes of peptidoglycan biosynthesis have
generated renewed interest as attractive targets for the development of new anti-mycobacterials.
One of the cytoplasmic enzymes, uridine diphosphate (UDP)-MurNAc-tripeptide ligase (MurE),
catalyses the addition of meso-diaminopimelic acid (m-DAP) into peptidoglycan in
Mycobacterium tuberculosis coupled to the hydrolysis of ATP. Mutants of M. tuberculosis MurE
were generated by replacing K157, E220, D392, R451 with alanine and N449 with aspartate, and
truncating the first 24 amino acid residues at the N-terminus of the enzyme. Analysis of the
specific activity of these proteins suggested that apart from the 24 N-terminal residues, the other
mutated residues are essential for catalysis. Variations in Km values for one or more substrates
were observed for all mutants, except the N-terminal truncation mutant, indicating that these
residues are involved in binding substrates and form part of the active site structure. These mutant
proteins were also tested for their specificity for a wide range of substrates. Interestingly, the
mutations K157A, E220A and D392A showed hydrolysis of ATP uncoupled from catalysis. The
ATP hydrolysis rate was enhanced by at least partial occupation of the uridine nucleotide
dipeptide binding site. This study provides an insight into the residues essential for the catalytic
activity and substrate binding of the ATP-dependent MurE ligase. Since ATP-dependent MurE
ligase is a novel drug target, the understanding of its function may lead to development of novel
inhibitors against resistant forms of M. tuberculosis.
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INTRODUCTION
Tuberculosis is an increasing global health problem. The emergence of totally drug-resistant
(TDR) strains of Mycobacterium tuberculosis poses a serious challenge, requiring the
discovery of new anti-TB drugs against these strains with potential novel mechanisms of
action (Velayati et al., 2009). Peptidoglycan, part of the cell envelope of M. tuberculosis,
plays a major role in preserving the structural integrity of the cell by withstanding the high
internal osmotic pressure. It is a giant macromolecule located on the outside of the
cytoplasmic membrane in most of eubacteria (Schleifer and Kandler, 1972). In M.
tuberculosis, the peptidoglycan consists of linear glycan chains with alternating units of N-
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acetyl-α-D-glucosamine (GlcNAc) and N-acetyl/N-glycolyl muramic acid (MurNAc/
MurNGl) substituted with a peptide side-chain that may be cross-linked to peptide of other
glycan strands (Mahapatra et al., 2005a). Due to their absence from animal cells,
peptidoglycan biosynthesis enzymes are attractive targets for antimicrobials.
Peptidoglycan biosynthesis is a complex process involving three major steps. In the first
step, MurA and subsequently MurB convert UDP-GlcNAc to UDP-MurNAc. The next step
is catalyzed by four ATP-dependent Mur ligases, MurC, MurD, MurE and MurF which
catalyze the addition of L-ala, D-glu, m-DAP/L-lys and D-ala-D-ala sequentially with the
hydrolysis of ATP. These ligases share a common reaction mechanism (Barreteau et al.,
2008).
From a multiple sequence alignment of MurC, MurD, MurE and MurF ligases from E. coli,
conserved residues were identified, which suggested that these genes evolved from a
common ancestral gene (Ikeda et al., 1990). Ten invariant amino acids, including 3 residues
in the ATP binding consensus sequence GxxGKT/G were recognized by comparing amino
acid sequences of 20 Mur synthetases including MurC, D, E, F, Mpl, folylpoly-γ-L-
glutamate synthetase (FPGS or FolC) from several bacteria, the C-terminal domain of
cyanophycin synthetase (CphA) from Synechocystis sp. and the poly-γ-glutamate synthetase
(CapB) from Bacillus anthracis (Bouhss et al., 1997; Bouhss et al., 1999). To evaluate the
roles of these conserved residues in catalysis and binding of the substrates in the Mur
superfamily, site-directed mutagenesis of these invariants were studied using MurC and
MurD from E. coli (Bouhss et al., 1997; Bouhss et al., 1999). This study was facilitated by
the availability of 3-D structural information for MurD in the presence of ligands (Bertrand
et al., 1997; Bertrand et al., 1999) and these invariants were found to be present in the active
site cleft of MurD as observed in its 3-D structure. Similar results showing lack of activity
with mutants of some of these invariant residues were reported for E. coli MurF (Eveland et
al., 1997).
From the alignment of a large number of MurE sequences, a short sequence was identified
as having two alternative conserved motifs characterized by the tetrapeptide sequences
DNPR (m-DAP recognition) and D(D/N)P(N/A) (L-lys recognition) (Dementin et al., 2001).
Thermatoga maritima MurE, which was shown to incorporate L-lys to UDP-N-
acetylmuramoyl dipeptide and also to add D-lys and m-DAP at 25% and 10% efficiencies
respectively relative to L-lysine, has the tetrapeptide sequence DDPR (Boniface et al.,
2006). Staphylococcus aureus and Streptococcus pneumoniae MurE, which incorporate L-
lys to UDP-N-acetylmuramoyl dipeptide, have DNPA and DDPN as the tetrapeptide
sequence respectively.
Construction and characterization of mutants play a major role in understanding the function
of specific residues in enzyme activity and substrate binding. This information along with
the three dimensional structure of the protein will help in the rational design of inhibitors. In
this study, truncation of the first 24 N-terminal amino acids and site directed mutagenesis of
some residues that are conserved in MurC, D, E, F, Mpl and FolC and some that are
conserved in all MurE orthologs but not in all the other members of the superfamily were
carried out in order to investigate their role in M. tuberculosis MurE (Mtb-MurE).
RESULTS
Conservation of active site amino acid residues across the bacterial MurE
The sequences of MurC, D, E and F from E. coli and MurE from T. maritima, S. aureus and
S. pneumoniae were aligned with the MurE of M. tuberculosis using the ClustalW program
and the final alignment was optimized manually (Fig. 1). The residues in boldface type can
Basavannacharya et al. Page 2
Protein Cell. Author manuscript; available in PMC 2014 March 24.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
be divided into two categories. In the first category are the residues invariant across Mur
synthetases, which are similar to those observed in studies on MurC and MurD (Bouhss et
al., 1997, 1999). These are D71, K157 belonging to the ATP binding motif GXXGKT/S,
E220, N243, H248, N344, N347, R377 and D392, numbered as per Mtb-MurE.
Interestingly, N344, which was found to be conserved among the sequences aligned in this
study, was not considered an invariant residue when MurD sequences were aligned (Bouhss
et al., 1999) but was identified as an invariant residue when MurC sequences were aligned
(Bouhss et al., 1997). N243 was identified as a further conserved residue during this
alignment. In the second category, the DNPR motif conserved in all m-DAP adding
enzymes, but not in all the other members of the Mur family, were looked at. The variation
in this motif changes the substrate specificity from m-DAP to L-lysine in S. aureus and S.
pneumoniae MurE. Intriguingly, T. maritima MurE adds D-lys and m-DAP in addition to L-
lys although less efficiently.
Generation and overexpression of Mtb-MurE mutants
Mutagenesis of Mtb-MurE resulted in the replacement of specific residue N449 by aspartate,
R451, K157, E220 and D392 residues by alanine; and the truncation of the first 24 N-
terminal amino acid residues. Analysis of the purified proteins by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 2A) revealed that all the six mutant
MurE proteins were overproduced to the same high level as the wild-type MurE and were
stable in the host strain without significant proteolysis. Under optimum protein expression
conditions around 3–5 mg of protein was purified from one liter of E. coli culture.
Enzymatic properties of the MurE mutants
The wild type and mutant proteins were characterized in terms of their substrate binding,
catalysis and substrate specificity using an ATPase activity assay. Initial velocity was
measured in all the experiments to ensure the inorganic phosphate formed as a result of
hydrolysis of ATP was well within the linear response of the reaction.
Specific activity for the mutant proteins using optimized conditions was found to be 0.03,
0.07, 0.11, 0.16 and 0.07 μmoles/min/mg for N449D, R451A, K157A, E220A and D392A
respectively (Fig. 2B) while the wild type showed 1.05 μmoles/min/mg. The specific
activity of the mutants was less than 15% of wild type, which nevertheless was still
detectable above background. Deletion of the first 24 residues at the N terminus of MurE
(MurEtr) did not lead to any significant variation in its activity compared to the wild type.
The specific activity obtained for MurEtr was 0.9 μmoles/min/mg protein.
Effect on kinetic parameters
Table 1 shows the kinetic parameters for endogenous substrates. Interestingly all the
mutations have led to significant variations in apparent Km values for more than one
substrate. For N449D, 4 fold increases in Km values were observed for ATP and m-DAP
whereas a decrease was observed for UDP-MurNAc-L-ala-D-glu. Although there was no
significant difference in Km value of ATP for R451A, the Km value for m-DAP was much
larger and that for UDP-MurNAc-L-ala-D-glu slightly lower. For K157A, a large variation
in the Km values for UDP-MurNAc-L-ala-D-glu and m-DAP was observed. A major
increase was observed for E220A and D392A in their Km values for ATP with similar
increase for UDP-MurNAc-L-ala-D-glu only with the E220A. No significant variations in
Km for any of the three substrates, Vmax and apparent Kcat values were observed in case of
MurEtr as compared to the wild type. A decrease in Vmax was observed for all the other
mutants. This is in agreement with the calculated apparent Kcat showing more than 10-fold
decrease with all single residue replacement mutants except E220A, which showed about a 2
fold decrease.
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Substrate specificity of mutant proteins
To better understand the interactions with mutated residues and the influence of the mutation
on the substrate specificity, experiments with various analogs of each substrate were carried
out (Tables 2-4). Interestingly wild type showed significant activity with DL-lanthionine
similar to that of m-DAP. N449D and MurEtr showed similar results to the wild type with
all the nucleotides, UDP-MurNAc peptides and amino acids, except D-lys, which showed a
slightly higher activity for N449D. A significant activity was observed in the presence of L-
lys, D-lys, DL-ornithine and D-glu for R451A with similar activities as wild type for all the
nucleotides and UDP-MurNAc peptides tested. Surprisingly, K157A, E220A and D392A
showed very high activity with all the amino acids, uridine sugar precursors and nucleotides
tested compared to wild type and moreover, reaching up to 100% of the standard assay in
many cases.
Effect of ATP, m-DAP and UDP-MurNAc-L-ala-D-glu on ATP hydrolysis
The substrate specificity experiments led us to investigate further the effect of ATP alone
and in combination with meso-diaminopimelic acid (m-DAP) and UDP-MurNAc-L-ala-D-
glu (Table 5). Wild type, N449D, R451A and MurEtr showed the lowest absorbance in the
presence of only ATP and enzyme, which does not change much in the presence of m-DAP,
whereas absorbance increased slightly in the presence of uridine sugar precursor similar to
all substrates without enzyme. K157A, E220A and D392A showed significant ATP
hydrolysis compared to wild type, N449D, R451A and MurEtr in the presence of only ATP
and enzyme, in the absence of other substrates. This activity was higher than the control
reaction but similar to that in the presence of m-DAP. The ATP hydrolysis activity further
increased significantly in the presence of uridine sugar precursors to a similar level to that of
the enzyme reaction with all the three substrates.
Crystal structure of MurE/ADP/dipeptide ternary complex
The ternary complex structure (PDB: 2xja) shows clear density for ADP with very little
other difference from the MurE/dipeptide complex (PDB: 2wtz). The refinement statistics
are in Table 6. The refined structure is depicted in Figs. 3 and 4 showing binding of ADP in
an analogous position to that in MurD.
DISCUSSION
Structural analysis of wild type Mtb-MurE, from our previous study, had revealed that the
first 24 N-terminal amino acid residues may not be involved in the active site structure of
MurE (Basavannacharya et al., 2010); hence, a truncated version of wild type MurE was
generated. The truncated MurE mutant showed activities similar to the wild type MurE,
providing further support that this deletion did not affect the activity nor the substrate
specificity of the recombinant enzyme.
The m-DAP of the peptidoglycan monomer unit plays a pivotal role in the integrity of the
peptidoglycan as it is directly involved in peptide cross-linkages (Glauner et al., 1988). m-
DAP is used in various transpeptidation reactions during the later stages of peptidoglycan
biosynthesis, which leads to the formation of D-ala- >m-DAP and m-DAP- >m-DAP cross
linkages (Glauner et al., 1988; Nanninga, 1991). Interestingly, peptidoglycan of some
bacterial species contain 3-hydroxy m-DAP or lanthionine as a natural substitute for m-DAP
(Inoue et al., 1979; Vasstrand et al., 1980; Kawamoto et al., 1981). It has been shown that in
m-DAP auxotrophs, L-allo-cystathionine (95%) and m-lanthionine (93%), sulfur containing
m-DAP analogs, were incorporated into the peptidoglycan of E. coli in in vivo conditions.
These are shown to be good substrates in addition to D-allo-cystathionine for the E. coli
enzyme (Mengin-Lecreulx et al., 1994) concluding that MurE was the cystathionine and
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lanthionine adding enzyme in vivo. Mycobacterium smegmatis has been shown to
incorporate lanthionine in m-DAP auxotrophs. Even though cells grow, they do not produce
normal peptidoglycan. The replacement of m-DAP with lanthionine but not cystathionine
suggested that the peptidoglycan biosynthesis in mycobacteria may have more constraints on
peptide composition than in E. coli (Consaul et al., 2005). Interestingly, in the case of M.
tuberculosis wild type MurE showed a similar activity with DL-lanthionine as m-DAP, but
much lower activity with L-cystathionine or any of the other amino acids. This result is
consistent with that observed in the mutant strains of E. coli (Mengin-Lecreulx et al., 1994)
and M. smegmatis (Consaul et al., 2005) demonstrating MurE specificity for the meso
isomer.
Asparagine 449, belonging to a well-known consensus DNPR motif (Gordon et al., 2001)
conserved in m-DAP adding enzymes, was mutated to aspartate in N449D to investigate its
role in substrate binding and incorporation of substrates, particularly m-DAP. The Km values
for m-DAP and ATP were increased by 4 fold whereas for UDP-MurNAc-L-ala-D-glu, there
was no significant change. These results suggested that this residue is involved in m-DAP
and ATP binding. Further evidence comes from the structure of E. coli MurE with the
product complex (Gordon et al., 2001), where the amino group of amide side chain of
Asn414 forms a hydrogen bond with the carboxylic group of m-DAP at the D-center (Fig.
5). This interaction gets disrupted when the equivalent Asn449 in Mtb-MurE was converted
to aspartate and loses the affinity for the substrate. But how this mutation is involved in ATP
binding is difficult to explain. A high degree of reduction, by 35 fold in the specific activity,
was reflected by 26 fold decrease in the turnover rate. The N449D mutation results in DDPR
motif present in T. maritima, a thermophilic bacterium which shows 25% and 10%
efficiency of incorporation of D-lys and m-DAP relative to L-lys (Boniface et al., 2006).
However, this mutation neither abolishes the incorporation of m-DAP, nor does it show any
activity with L-lys. This is not surprising as the D-carbon (distal recognition site) of D-lys is
involved in interaction with the residues (Glu468, Gly464, Asp413, Asn414 and Arg416) of
E. coli MurE (Fig. 5) and the L-carbon gets acylated on its ε-amino group similar to m-DAP
(Gordon et al., 2001). Similar observations were made in E. coli in vivo (Mengin-Lecreulx et
al., 1994).
Another residue arginine 451, also part of the DNPR motif, is also conserved in organisms
incorporating m-DAP at the third position of stem peptide of the UDP-MurNAc
pentapeptide. This residue is believed to be responsible for determining the specificity of m-
DAP incorporation into the peptidoglycan in E. coli (Gordon et al., 2001). The R451A
mutant was made to investigate further its role in substrate specificity. There was a 6 fold
increase observed in Km value for m-DAP whereas a 5 fold decrease was seen for UDP-
MurNAc-L-ala-D-glu and no difference for ATP. These results support the involvement of
this residue in m-DAP incorporation. Evidence from the E. coli MurE product structure
strongly supports this role for this residue. Two amino groups from guanidinium side chain
of Arg416 are involved in hydrogen bonding with carboxylic group of m-DAP at the D
center as well as at the L center (Fig. 5) (Gordon et al., 2001). The corresponding arginine at
position 451 in Mtb-MurE loses these interactions when replaced by alanine, thereby
showing a reduced affinity for m-DAP, but the negative role of this residue in UDP-
MurNAc-L-ala-D-glu binding as seen by decrease in the Km value is difficult to understand.
R451A also showed loss of activity by 15-fold which agrees well with the 20-fold reduction
in the turnover rate of this enzyme. The resulting mutation has the DNPA sequence which is
present in S. aureus. This Gram-positive organism incorporates L-lys at the third position of
the stem peptide in the peptidoglycan precursor. This mutation in MurE of M. tuberculosis
did not abolish the incorporation of m-DAP, instead additionally it showed significant
activity with L-lys. It also showed substantial activity with DL-lanthionine, D-lys, D-glu and
DL-ornithine.
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Lysine at position 157 belongs to a well-known consensus ATP binding site (Walker et al.,
1982; van der Wolk et al., 1995). Surprisingly, the Km value of K157A for ATP was reduced
2 fold. In the three dimensional structure of Mtb-MurE/ADP/Mg2+ complex (Fig. 3), this
lysine forms interacting bonds through its amino group with the β-phosphate of ADP similar
to E. coli MurD at position 115 (Bertrand et al., 1999). It is clear from the structural data,
that the interaction with ε-amino group is lost when lysine is replaced by alanine. The same
mutation showed apparent stronger affinity for the other two substrates UDP-MurNAc-L-
ala-D-glu and m-DAP indicated by their reduced Km value. This is in contrast to the data
observed for mutation of the equivalent residues in E. coli MurC and MurD which showed
an increase in Km for ATP and uridine sugar precursor (Bouhss et al., 1997; Bouhss et al.,
1999). For K157A, the turnover rate was 16-fold lower than that of wild type with 10-fold
reduction in its enzyme activity strongly suggesting its role in catalysis. This is in agreement
with the results with MurC and MurD (Bouhss et al., 1997; Bouhss et al., 1999).
The Km value for E220A was significantly increased by 7 fold for ATP giving a clue that
this residue has a crucial role to play in ATP binding. This is predicted from the fact that this
residue belongs to the second ATP binding motif (Walker et al., 1982). The residue is
conserved across various ATP binding proteins including FolC (Bognar et al., 1987). This
residue is generally involved in the chelation of the ATP-Mg2+ complexes (Walker et al.,
1982; Glaser et al., 1991; Story and Steitz, 1992; Mitchell and Oliver, 1993). The Mtb-
MurE/ADP/Mg2+ complex reveals that E220 is involved in interactions with Mg2+ which in
turn binds ADP (Fig. 3) similar to the corresponding E157 in E. coli MurD binding to ATP
through Mg2+ (Bertrand et al., 1999). When this interaction is disrupted by the mutation, the
affinity of ATP binding is lowered. The Km value for UDP-MurNAc-L-ala-D-glu was 6 fold
higher whereas m-DAP showed an insignificant decrease in Km value. A similar result
showing a drastic increase in Km for the uridine sugar precursor was observed for the
analogous mutation of MurD in E. coli (Bouhss et al., 1999). E220A demonstrated a specific
activity 6 fold less with 2 fold decrease in turnover rate. This is in contrast to the results
obtained with E. coli MurC and MurD (Bouhss et al., 1997; Bouhss et al., 1999) and MurF
(Eveland et al., 1997) where there was a greater loss of activity with these proteins caused
by the analogous mutation.
In D392A where aspartate 392 is replaced by alanine, a 5 fold increase in the Km value was
observed for ATP whereas for other substrates, it was of the same order of magnitude as that
of wild type. In the three dimensional structure of Mtb-MurE/ADP/Mg2+ complex (Fig. 3),
this residue has been shown to make interactions with the ribose moiety of ADP through its
carboxylate oxygens, similar to the equivalent residue Asp317 in E. coli MurD (Bertrand et
al., 1999). When this residue is mutated to alanine the mutation results in loss of these
interactions thereby losing the affinity for ATP. In MurD mutant of E. coli, a strong increase
in the Km value for ATP and uridine sugar precursor was detected (Bouhss et al., 1999). The
D392 residue appears to play a crucial role in catalysis as there was a reduction in the
specific activity and turnover number by 15-fold. This is in agreement with that obtained in
analogous mutants of E. coli MurC and MurD (Bouhss et al., 1997; Bouhss et al., 1999).
K157A, E220A and D392A showed significant activity with all the amino acids, nucleotides
and uridine sugars tested to a level comparable to that of m-DAP, ATP and UDP-MurNAc-
L-ala-D-glu respectively, indicating that these mutations may have caused ATP hydrolysis
to be uncoupled from the enzyme reaction.
Further investigation was done only in the presence of ATP in order to gain more
understanding of the above results. The results found from this experiment were intriguing.
There seem to be significant ATP hydrolysis taking place with K157A, E220A and D392A
even in the absence of other substrates contrary to that of wild type, N449D, R451A and
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MurEtr. The hydrolysis rate of the mutants remained same after the addition of m-DAP,
whereas it significantly increased in the presence of uridine sugar precursor. The binding of
MurNAc, the common moiety in all the uridine sugars tested, seem to cause more ATP
hydrolysis by an allosteric effect. The high rate of phosphate release with different amino
acids, nucleotides and uridine sugar precursors with K157A, E220A and D392A is due to
the uncoupled hydrolysis of ATP by the enzyme. ATPase contamination in the preparations
of these mutants is unlikely as the purification was carried out under identical conditions for
these mutants as that for wild type, N449D, R451A and MurEtr. The baseline reactions with
only the mutant proteins did not show any phosphate contamination (Table 7). It is well
established that the ATPase activity is coupled with ligase activity for the wild type protein
(Basavannacharya et al., 2010). Hence, the residues involved in these mutations are likely
responsible for coupling the ATPase activity with the ligase activity.
The findings in this study contribute significantly to the understanding of the residues
essential for catalytic activity, substrate binding and specificity of MurE of M. tuberculosis.
In particular, it identifies the residues that couple hydrolysis of ATP to the reaction. These
results along with the three dimensional structure of Mtb-MurE will aid in the development
of inhibitors targeting the drug-resistant strains of M. tuberculosis.
MATERIALS AND METHODS
Strains, plasmids and growth conditions
E. coli DH5α (Bioline, UK) and BL21 (DE3) (Promega Corporation) strains were used in
this study. Oligonucleotide primers were synthesized by MWG Biotech, Germany.
Restriction enzymes were obtained from New England Biolabs, UK. All other media and
chemicals were purchased from Sigma unless otherwise mentioned. LB broth and agar
media were used for growing cells. Growth was monitored by measuring the culture
absorbance at 600 nm. Standard procedures for endonuclease digestion, ligation and agarose
electrophoresis were used (Sambrook and Russell, 2001).
Generation of Mtb-MurE mutants
pET28b-murE (pSBC1), a plasmid harbouring the wild type Mtb-murE gene generated in a
previous study (Basavannacharya et al., 2010) was used as the template for the mutagenic
PCR. Site-directed mutagenesis was carried out using the QuikChange® Lightning site-
directed mutagenesis kit (Strategene) according to the manufacturer’s instructions.
Truncation of the first 24 amino acid residues at the N-terminal end (72 base pairs) was
based on similar principle as site-directed mutagenesis. All primers used in this mutagenesis
study are described in Table 8. DNA sequence analysis was done to confirm that mutation
has taken place at the desired positions. The plasmids with amino acid residue mutations
were designated as pSBC1K157A, pSBC1E220A, pSBC1D392A, pSBC1N449D and
pSBC1R451A, and that with the truncated MurE was termed as pSBC1Etr.
Expression and purification of wild type and mutant MurE proteins
The expression and purification of wild type and mutant proteins was carried out as
described earlier (Basavannacharya et al., 2010), with slight modifications. On harvesting
the cultures, the cell pellets were washed and resuspended in ice-cold buffer A containing
0.02 M Bis-tris propane·HCl (pH 8.5), 0.1 M NaCl and 0.03 M imidazole. Once the bound
proteins were eluted from Ni2+-NTA resin with 100 mM imidazole in buffer A, they were
diluted in storage buffer [0.02 M Bis-tris propane·HCl (pH 8.5) and 0.1 M NaCl] and
reconcentrated to remove imidazole. Protein concentration was estimated by Bradford assay
(Bradford, 1976) using bovine serum albumin as a standard and analyzed by SDS-PAGE
(Laemmli, 1970). Glycerol was added to a final concentration of 10% (v/v) and the proteins
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were stored in aliquots at −80°C. The resulting mutant proteins were designated as N449D,
R451A, K157A, E220A, D392A and MurEtr.
MurE activity assay
MurE enzyme activity was assayed as described previously (Basavannacharya et al., 2010),
by measuring the release of inorganic phosphate following ATP hydrolysis using Pi
ColorLock Gold kit (Innova Biosciences). The enzyme activity assay was performed in a
final volume of 50 μL in the presence of 25 mM Bis-tris propane·HCl pH 8.5, 5 mM MgCl2,
250 μM ATP, 100 μM UDP-MurNAc dipeptide (UDP-MurNAc-L-ala-D-glu) and 1 mM m-
DAP at 37°C. The absorbance was measured at 635 nm using FLUOstar Optima plate reader
(BMG Labtech). Wild type MurE was used as a positive control in all the experiments for
comparison with the mutant proteins. The conditions were kept constant to help compare the
results across different mutants and wild type protein. Absorbance values were corrected for
background absorbance of reaction mixtures and any non-enzymatic hydrolysis of ATP in
the absence of the enzyme. In addition, individual components of the assay were checked
with the assay reagents to monitor the background absorbance. A standard phosphate curve
was generated using the inorganic phosphate provided along with the kit to calculate the
specific activity. All assays were performed in triplicate. The specific activity of the protein
is expressed as picomoles of inorganic phosphate released during the reaction per minute per
milligram of the recombinant protein.
Protein dependence
Protein dependence was determined for all the mutant proteins in addition to wild type.
Protein was diluted in 25 mM Bis-tris propane·HCl (pH 8.5) according to the quantity to be
used. The amount of the protein used for the assay ranged 25–200 ng for wild type, D392A
and MurEtr, and 100–1200 ng for rest of the mutants.
Determination of the kinetic constants
For determination of the kinetic constants, the assay was done at various concentrations of
one substrate and fixed concentration of the others. For ATP, UMAG and m-DAP, varying
concentrations of ATP at 10–500 μM, UMAG at 5–250 μM and m-DAP at 25–2500 μM
with fixed concentrations of 250 μM ATP, 100 μM UMAG and 1000 μM m-DAP
respectively were used. The protein quantity used for all subsequent assays were 100 ng of
wild type, 700 ng of N449D and K157A, 500 ng of R451A, 150 ng of E220A, 600 ng of
D392A and 100 ng of MurEtr. Data was fitted to the Hanes’ plot equation
 to calculate apparent Km and Vmax by linear regression.
Determination of substrate specificity
Different amino acids, nucleotides and MurNAc substitutes were used to determine the
substrate specificity of mutants of MurE. 1000 μM m-DAP or other amino acids, 250 μM
ATP or other nucleotides, 100 μM UDP-MurNAc-L-ala-D-glu or other MurNAc substitutes
were added to the assay mix to initiate the reaction at 37°C for 30 min. The rest of the assay
set up was as described earlier. In all cases, the experiment was done in triplicate and the
standard deviations are indicated by error bars (n = 3).
Effect of ATP, m-DAP and UDP-MurNAc-L-ala-D-glu on ATP hydrolysis
Complete and control reactions were set up as described previously. Three reactions were
set up, first with ATP and enzyme, second with ATP, UDP-MurNAc-L-ala-D-glu and
enzyme, third with ATP, m-DAP and enzyme. The rest of the assay set up was as described
earlier.
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Crystal structure of ternary complex
Crystals of the MurE ternary complex were grown in the presence of 0.25 mM ADP, 0.25
mM UDP-MurNAc-L-ala-D-glu, 0.35 M MgCl2, 0.1 M Tris pH 8.5 and 13% PEG 8000.
Data was collected on beamline I04 at the Diamond Light Source. The structure was solved
using the MurE/dipeptide binary complex 2 wtz (Basavannacharya et al., 2010) as a starting
model for refinement and figures were prepared using CCP4MG.
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ABBREVIATIONS
FolC folylpoly-γ-L-glutamate synthetase
Mpl UDP-N-acetylmuramate:L-alanyl-γ-D-glutamyl-meso-diaminopimelate ligase
MurC UDP-N-acetylmuramate:L-alanine ligase
MurD UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase
MurE UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:meso-diaminopimelate ligase
MurF UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-diaminopimelate:D-
alanyl-D-alanine ligase
UMAG UDP-N-acetylmuramoyl-L-alanyl-D-glutamate
TDR-TB totally drug-resistant tuberculosis
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Figure 1. Multiple sequence alignment of MurE protein
MurE from M. tuberculosis (MYCTU) was aligned with other homologous proteins from T.
maritima (THEMA) (28%), S. aureus (STAAU) (25%), S. pneumoniae (STRPN) (25%),
and E. coli (ECOLI) (37%) and similarly sequence alignment with other Mur ligases from E.
coli MurD (16%), MurC (17%) and MurF (23%). Only the clusters containing the conserved
amino acid residues and the DNPR motif (in bold) for m-DAP adding and L-lys adding
MurE of different organisms are shown. Percentage similarity is mentioned in parenthesis.
The numbering refers to Mtb-MurE. The alignment function was performed by ClustalW.
Hyphens represent a gap in the sequence.
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Figure 2. Comparison of wild type and mutant MurE from M. tuberculosis
(A) SDS-PAGE of purified fractions showing lane 1: protein molecular mass markers,
individual molecular mass in kDa is indicated to the left; lane 2: wild type; lane 3: N449D;
lane 4: R451A; lane 5: K157A; lane 6: E220A; lane 7: D392A; lane 8: MurEtr. In all cases
4–6 μg of protein loaded on the gel. (B) Comparison of specific activity of wild type MurE
with mutant proteins. The reaction consisted of Bis-tris-propane-HCl (pH 8.5), MgCl2, ATP,
UDP-MurNAc dipeptide, m-DAP and enzymes at the concentration described in the
experimental procedures. In all cases, enzymes were omitted in the control reactions. Y-axis
represents the amount of Pi released in μmoles/min/mg of protein. Error bars indicate the
standard deviation. SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis.
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Figure 3. Three dimensional structure of Mtb-MurE/ADP/Mg2+ complex
A close up of the active site of M. tuberculosis MurE showing the 3 mutated residues close
to ADP in dark green and other side chains interacting with ADP in light green labeled with
residue numbers at Calpha. ADP and UAG are shown as tan cylinders, magnesium as gray
spheres and a highly ordered water as a red sphere. Hydrogen bonds are shown as dotted
lines. Domain 1 is in coral, domain 2 is in blue and domain 3 is in yellow and truncated at
residue 394.
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Figure 4. Location of the residues subjected to mutagenesis
Amino acid residues that were mutated are indicted by ball and stick side chains labeled by
residue number in green, in the crystal structure of MurE of M. tuberculosis colored by
domains (1 in coral, 2 in blue, and 3 in yellow). The ligands UAG and ADP are shown by
tan cylinder models, and Mg2+ is shown as gray spheres.
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Figure 5. Structure of the E. coli MurE product (1e8c)
The product UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diamino-
heptanedioate (UMT) is shown in green and contacting side chains in pink. Hydrogen bonds
are shown as dotted lines.
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Table 1
Kinetic parameters of wild type and mutant MurE proteins for endogenous substrates
protein app KmATP (mM) app KmUMAG (mM) app Kmm-DAP (mM) app Vmax (nmol/min) [mg of protein]−1 app Kcat (min−1)
wild type 0.017 ± 0.0007 0.024 ± 0.0015 0.078 ± 0.004 790 ± 28 78 ± 2
N449D 0.060 ± 0.005 0.007 ± 0.0003 0.324 ± 0.001 69 ± 3 3 ± 0.2
R451A 0.015 ± 0.001 0.005 ± 0.0001 0.473 ± 0.005 71 ± 4 4 ± 0.1
K157A 0.008 ± 0.0006 <0.005 0.012 ± 0.001 90 ± 7 5 ± 0.4
E220A 0.123 ± 0.01 0.148 ± 0.005 0.052 ± 0.002 320 ± 20 34 ± 2
D392A 0.100 ± 0.008 0.016 ± 0.0006 0.113 ± 0.008 70 ± 7 6 ± 0.3
MurEtr 0.021 ± 0.004 0.019 ± 0.0022 0.065 ± 0.0016 709 ± 0.5 67 ± 1.2
app: apparent; UMAG: UDP-MurNAc-L-ala-D-glu
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Table 2
Substrate specificity of different amino acids with wild type and mutant proteins
relative activity (%)a
amino acid wild type N449D R451A K157A E220A D392A MurEtr
m-DAP 100 ± 7.5 100 ± 6.8 100 ± 8.9 100 ± 9.2 100 ± 9.5 100 ± 5.6 100 ± 1.2
DL-lanthionine 82 ± 5.1 76 ± 4.3 78 ± 3.8 100 ± 8.7 83 ± 6.3 82 ± 4.5 97 ± 2.4
L-cystathionine 12 ± 0.6 0 34 ± 3 100 ± 9.1 100 ± 7.6 81 ± 5.7 3 ± 0.8
L-lys 7 ± 0.6 2 ± 0.12 45 ± 3.6 100 ± 8.6 100 ± 7.9 84 ± 6.8 9 ± 0.43
D-lys 9 ± 0.35 37 ± 3 62 ± 5 100 ± 6.9 100 ± 8.8 78 ± 6.1 7 ± 0.55
L-ala 12 ± 0.82 0 0 100 ± 8.6 100 ± 7.7 99 ± 6.8 3 ± 0.21
D-glu 13 ± 0.42 6 ± 0.4 100 ± 5.9 92 ± 6.8 95 ± 7.2 88 ± 5.8 3 ± 0.36
D-ala-D-ala 5 ± 0.3 1 ± 0.07 18 ± 1.8 100 ± 7.2 98 ± 8.3 88 ± 6.9 1 ± 0.67
Dl-ORNITHINE 8 ± 0.72 8 ± 0.56 8 ± 6.9 85 ± 7.2 90 ± 5.7 86 ± 7 2 ± 0.15
aActivity with m-DAP was used as 100% for each protein. m-DAP: meso-diaminopimelic acid.
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Table 3
Substrate specificity of different uridine sugar precursors with wild type and mutant proteins
relative activity (%)a
nucleotides wild type N449D R451A K157A E220A D392A MurEtr
ATP 100 ± 6.8 100 ± 8.1 100 ± 7.4 100 ± 6.7 100 ± 5.5 100 ± 4.8 100 ± 5.4
GTP 30 ± 2.5 0 17 ± 1.1 98 ± 3.8 100 ± 6.2 100 ± 7.7 30 ± 1.8
UTP 17 ± 1.5 0 5 ± 0.35 100 ± 6 92 ± 5.8 99 ± 6.8 5 ± 0.55
UTP 14 ± 0.98 0 0 83 ± 7.1 82 ± 5.7 96 ± 4.6 6 ± 0.21
aActivity with ATP was used as 100% for each protein.
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Table 4
Substrate specificity of different nucleotides with wild type and mutant proteins
relative activity (%)a
UDP-MurNAc peptides wild type N449D R451A K157A E220A D392A MurEtr
UDP-MurNAc dipeptide 100 ± 4.7 100 ± 6.9 100 ± 7.5 100 ± 5.8 100 ± 7.7 100 ± 4.7 100 ± 5.4
MurNAc 14 ± 0.87 14 ± 0.94 17 ± 0.77 98 ± 6.6 100 ± 5.8 100 ± 5.8 5 ± 0.68
UDP-MurNAc tripeptide 8 ± 0.73 20 ± 1.1 3 ± 0.2 96 ± 6.8 93 ± 5.7 98 ± 8.8 5 ± 0.37
UDP-MurNAc pentapeptide 15 ± 0.97 16 ± 0.88 18 ± 0.67 97 ± 7.4 99 ± 6.8 83 ± 4.6 4 ± 0.11
aActivity with UDP-MurNAc dipeptide was used as 100% for each protein.
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Table 5
Activity in the presence of different components of the MurE reaction with the wild type and mutant proteins
relative absorbance (%)a
different conditions wild type N449D R451A K157A E220A D392A MurEtr
ATP + enzyme 29 ± 2.4 37 ± 3.6 39 ± 2.7 77 ± 4.1 66 ± 3.8 70 ± 4.2 19 ± 1.3
ATP + enzyme + UDP MurNAc dipeptide 52 ± 3.2 65 ± 4.2 64 ± 3.8 85 ± 4.4 89 ± 6.2 98 ± 7.3 36 ± 2.6
ATP + enzyme + m-DAP 28 ± 2.1 34 ± 2.7 38 ± 1.9 73 ± 4.5 66 ± 3.8 67 ± 2.4 21 ± 2.0
ATP + UDP MurNAc dipeptide + m-DAPb 48 ± 1.4 59 ± 2.5 58 ± 3.1 55 ± 1.9 62 ± 2.3 66 ± 3.2 38 ± 3.5
ATP + enzyme + UDP MurNAc dipeptide + m-DAPc 100 ± 5.4 100 ± 4.9 100 ± 5.2 100 ± 4.6 100 ± 6.2 100 ± 4.8 100 ± 6.6
aActivity with enzyme reaction was used as 100% for each protein.
bControl reaction mixture contains ATP, UDP-MurNAc dipeptide and m-DAP but no enzyme.
c
Enzyme reaction mixture contains Mtb-MurE, ATP, UDP-MurNAc dipeptide and m-DAP.
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Table 6
Data collection and refinement statistics
ligand combination UMAG + ADP
space group P1
chains per unit cell 4
completeness (%) 95.9
multiplicity 3.7
average Rmerge 0.12
average I/σ 9.1
outer shell resolution (Å) 3.00–3.16
outer shell Rmerge 0.57
outer shell I/σ 2.6
refined R factor 0.189
final Rfree 0.258
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Table 7
Absorbance of individual assay components at 635 nm
different conditions A635 nm
ATP alone 0.53
UDP-MurNAc dipeptide alone 0.47
m-DAP alone 0.29
wild type 0.29
N449D 0.28
R451A 0.28
K157A 0.27
E220A 0.29
D392A 0.30
MurEtr 0.26
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Table 8
Mutagenic oligonucleotides
plasmid mutationa oligonucleotideb
pSBC1N449D N449D 5′-GTCACCGACGACGACCCGCGTGACGAAG-3′
pSBC1R451A R451A 5′-GACGACAACCCGGCTGACGAAGATCCCACG-3′
pSBC1K157A K157A 5′-AACGTCCGGCGCGACCACCACCACCTATC-3′
pSBC1E220A E220A 5′-ACACCGTGGTCATGGCGGTGTCCAGCCACG-3′
pSBC1D392A D392A 5′-CGCTGGTCGCCTACGCGCAC-3′
pSBC1MurEtr 24 residues 5′-CCTGGTGCCGCGCGGCAGCCAggcttgcgccccaacgccgtc-3′c
aAmino acids are represented by their one-letter abbreviation and the number indicates the location of the mutated residue in the amino acid
sequence of MurE from M. tuberculosis.
b
Mutations of the murE gene sequence that have been introduced in the oligonucleotides are indicated in bold.
c
Primers for truncation of N-terminal residues of murE with bases in upper and lower case representing sequence flanking the 72-base-pair region
to be truncated.
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